Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study. (Q34130128)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20843935%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20843935%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20843935%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

David Ulmert

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20843935%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Hans Lilja

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20843935%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Angel M Cronin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20843935%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Thomas Björk

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20843935%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Jonas Manjer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20843935%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Peter M Nilsson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20843935%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Anders Dahlin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20843935%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Anders Bjartell

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20843935%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Peter T Scardino

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20843935%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

language of work or name

English

0 references

publication date

14 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20843935%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20843935%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

341

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20843935%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

c4521

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20843935%20AND%20SRC:MED&resulttype=core&format=json

Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication

13 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Effect of dutasteride on the risk of prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Prostate cancer early detection. Clinical practice guidelines in oncology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Prostate specific antigen best practice statement: 2009 update.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Prostate specific antigen for early detection of prostate cancer: longitudinal study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Prostate-Cancer Screening

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Screening and prostate-cancer mortality in a randomized European study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Mortality results from a randomized prostate-cancer screening trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Clinical risk factors, DNA variants, and the development of type 2 diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Statistical methods to correct for verification bias in diagnostic studies are inadequate when there are few false negatives: a simulation study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Estimating the empirical Lorenz curve and Gini coefficient in the presence of error with nested data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Finasteride as a chemopreventive agent in prostate cancer: impact of the PCPT on urologic practice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Populations at high risk for prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Validity of a Population-Based Cancer Register in Sweden An Assessment of Data Reproducibility in the South-East Region Prostate Cancer Register

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Total, free, and percent free prostate-specific antigen levels among U.S. men, 2001-04.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

Needle Biopsies on Autopsy Prostates: Sensitivity of Cancer Detection Based on True Prevalence

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939950

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20843935

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20843935

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20843935

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.C4521

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20843935%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20843935%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

PubMed publication ID

20843935

1 reference